
Ensign Peak Advisors’s West Pharmaceutical WST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.5M | Sell |
93,576
-14,994
| -14% | -$3.28M | 0.04% | 312 |
|
2025
Q1 | $24.3M | Sell |
108,570
-35,237
| -25% | -$7.89M | 0.05% | 277 |
|
2024
Q4 | $47.1M | Sell |
143,807
-18,844
| -12% | -$6.17M | 0.08% | 197 |
|
2024
Q3 | $48.8M | Sell |
162,651
-2,094
| -1% | -$629K | 0.09% | 188 |
|
2024
Q2 | $54.3M | Sell |
164,745
-68,023
| -29% | -$22.4M | 0.1% | 174 |
|
2024
Q1 | $92.1M | Buy |
232,768
+97,147
| +72% | +$38.4M | 0.17% | 120 |
|
2023
Q4 | $47.8M | Buy |
135,621
+23,496
| +21% | +$8.27M | 0.09% | 192 |
|
2023
Q3 | $42.1M | Sell |
112,125
-43,690
| -28% | -$16.4M | 0.09% | 185 |
|
2023
Q2 | $59.6M | Sell |
155,815
-3,379
| -2% | -$1.29M | 0.12% | 151 |
|
2023
Q1 | $55.2M | Sell |
159,194
-32,074
| -17% | -$11.1M | 0.12% | 161 |
|
2022
Q4 | $45M | Buy |
191,268
+67,489
| +55% | +$15.9M | 0.1% | 181 |
|
2022
Q3 | $30.5M | Buy |
123,779
+30,489
| +33% | +$7.5M | 0.08% | 216 |
|
2022
Q2 | $28.2M | Buy |
93,290
+60,511
| +185% | +$18.3M | 0.07% | 227 |
|
2022
Q1 | $13.5M | Buy |
32,779
+1,602
| +5% | +$658K | 0.03% | 364 |
|
2021
Q4 | $14.6M | Buy |
31,177
+13,283
| +74% | +$6.23M | 0.03% | 383 |
|
2021
Q3 | $7.6M | Sell |
17,894
-2,213
| -11% | -$940K | 0.02% | 506 |
|
2021
Q2 | $7.22M | Sell |
20,107
-1,380
| -6% | -$496K | 0.01% | 522 |
|
2021
Q1 | $6.06M | Sell |
21,487
-469
| -2% | -$132K | 0.01% | 559 |
|
2020
Q4 | $6.22M | Buy |
21,956
+594
| +3% | +$168K | 0.01% | 539 |
|
2020
Q3 | $5.87M | Buy |
21,362
+14,212
| +199% | +$3.91M | 0.01% | 578 |
|
2020
Q2 | $1.62M | Sell |
7,150
-51,507
| -88% | -$11.7M | ﹤0.01% | 1082 |
|
2020
Q1 | $8.93M | Hold |
58,657
| – | – | 0.03% | 376 |
|
2019
Q4 | $8.82M | Buy |
+58,657
| New | +$8.82M | 0.02% | 482 |
|